| Progress Industries | |
|
1017 E 7th St N Newton IA 50208-2141 | |
| (641) 792-6119 | |
| (641) 792-0337 |
| Full Name | Progress Industries |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 1017 E 7th St N, Newton, Iowa |
| Authorized Official Name and Position | Dan Skokan (CEO) |
| Authorized Official Contact | 6417926119 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Progress Industries 1017 E 7th St N Newton IA 50208-2141 Ph: (641) 792-6119 | Progress Industries 1017 E 7th St N Newton IA 50208-2141 Ph: (641) 792-6119 |
| NPI Number | 1376612580 |
|---|---|
| Provider Enumeration Date | 11/06/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376612580 | NPI | - | NPPES |
| 2228643 | Other | IA | ARO - REMEDIAL SERVICES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (Iowa) | Primary |
News Archive
Stereotaxis, Inc. today announced the completion of the first 50 clinical procedures using the Company's new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia.
Elan Corporation, plc today announced that it has commenced a Phase 2, placebo-controlled, safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder (BPD 1) to delay the time to occurrence of mood episodes.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced positive results from its Phase 2 clinical study evaluating luliconazole, one of the most potent and broad spectrum topical antifungal agents, in patients with tinea pedis (athlete's foot). The study was designed to assess the effectiveness of 1% luliconazole cream applied once daily for 14 days compared with once daily for 28 days.
About half of all cancer patients have a mutation in a gene called p53, which allows tumors to survive and continue growing even after chemotherapy severely damages their DNA.
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them. Blocking myeloid-derived suppressor cells and regulatory T-cell reconstitution improved adoptive T-cell therapy, an immunotherapy designed to suppress tumor activity.
› Verified 8 days ago
Progress Industries Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1017 E 7th St N, Newton, IA 50208 Phone: 641-792-6119 Fax: 641-792-0337 | |
Capstone Behavioral Healthcare, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1123 1st Ave E, #200, Newton, IA 50208 Phone: 641-792-4012 Fax: 641-791-0697 | |
Progress Industries Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1017 E 7th St N, Newton, IA 50208 Phone: 641-792-6119 Fax: 641-792-0337 | |
Pathways Psychotherapy Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1502 W 9th St S, Newton, IA 50208 Phone: 641-521-9402 | |
Wellnite Medical Group Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 102 N 2nd Ave E, Newton, IA 50208 Phone: 877-644-6008 | |
Pal'ay Christian Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 207 S 2nd Ave E, Newton, IA 50208 Phone: 641-831-5336 Fax: 855-585-6222 |